CGNX.NASDAQCognex CORP

Form 4: Cognex EVP Gerst Reports Equity Transactions

Sentiment:

Insider Transaction Report


Cognex EVP Carl Gerst reported recent equity transactions, including the vesting of restricted stock units, tax-related share disposition, and new grants of stock options and restricted stock units.

Summary

  • Carl Gerst, Executive Vice President of Vision & ID Products at Cognex Corp (CGNX), reported equity transactions on February 18, 2026.
  • Acquired 5,570 shares of Common Stock through the vesting of Restricted Stock Units (RSUs).
  • Disposed of 1,766 shares of Common Stock at a price of $56.72 per share to satisfy tax withholding obligations related to the RSU vesting.
  • Beneficially owns 3,804 shares of Common Stock directly following these reported transactions.
  • Received a new grant of 24,854 Non-Qualified Stock Options with an exercise price of $57.09, which will vest in five approximately equal annual installments on the first through fifth anniversaries of the February 17, 2026 grant date.
  • Received a new grant of 24,085 Restricted Stock Units, which will vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 17, 2026 grant date, respectively.
  • Holds various other outstanding Non-Qualified Stock Options and Restricted Stock Units from previous grants.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting ongoing executive compensation and retention efforts, which are standard for publicly traded companies and align management incentives with long-term company performance.

Positives

  • The vesting of 5,570 Restricted Stock Units indicates the fulfillment of performance or tenure conditions for executive compensation.
  • The grant of 24,854 new Non-Qualified Stock Options aligns management incentives with the company's long-term stock performance.
  • The grant of 24,085 new Restricted Stock Units further strengthens executive retention and aligns interests with long-term shareholder value.

Negatives

  • The disposition of 1,766 shares of Common Stock for tax withholding purposes reduces the direct beneficial ownership of the executive, although this is a standard practice for RSU vesting.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings provide transparency into executive compensation and insider ownership, which can influence investor perception of management's alignment with shareholder interests. These routine grants and vestings are typical for publicly traded companies and reflect ongoing executive incentive programs.

Stakeholder Impact

  • Shareholders: The equity grants align the executive's financial interests with the long-term performance of the company's stock, potentially fostering greater commitment to shareholder value creation.
  • Employees: Standard executive compensation practices, including equity grants, can signal stability in leadership and a commitment to performance-based incentives across the organization.

Next Steps

  • Vesting of 24,854 Non-Qualified Stock Options in five approximately equal annual installments on the first through fifth anniversaries of February 17, 2026.
  • Vesting of 24,085 Restricted Stock Units approximately 20%, 30%, and 50% on the first, second, and third anniversaries of February 17, 2026.
  • Continued vesting of other outstanding Restricted Stock Units and exercisability of other outstanding Non-Qualified Stock Options according to their respective schedules.

Key Dates

DateDescription
02/19/2020Grant date for 60,000 Non-Qualified Stock Options.
02/18/2021Grant date for 80,000 Non-Qualified Stock Options.
02/22/2023Grant date for 74,720 Non-Qualified Stock Options.
02/21/2024Grant date for 94,298 Non-Qualified Stock Options; Vesting start for 8,791 Restricted Stock Units.
02/18/2025Grant date for 5,570 Restricted Stock Units.
02/20/2025Grant date for 126,800 Non-Qualified Stock Options; Vesting start for 18,256 Restricted Stock Units.
10/30/2025Grant date for 150,000 Non-Qualified Stock Options.
02/17/2026Grant date for 24,854 Non-Qualified Stock Options; Grant date for 24,085 Restricted Stock Units.
02/18/2026Vesting of 5,570 Restricted Stock Units; Disposition of 1,766 shares for tax withholding.
02/19/2026Signature date of reporting person.
02/21/2026Expiration date for 8,791 Restricted Stock Units.
02/17/2027First vesting anniversary for 24,854 Non-Qualified Stock Options; First vesting anniversary for 24,085 Restricted Stock Units.
02/20/2027Expiration date for 18,256 Restricted Stock Units.
02/18/2028Expiration date for 5,570 Restricted Stock Units.
02/20/2028Expiration date for 20,000 Non-Qualified Stock Options.
02/17/2029Expiration date for 24,085 Restricted Stock Units.
02/19/2029Expiration date for 60,000 Non-Qualified Stock Options.
02/18/2030Expiration date for 80,000 Non-Qualified Stock Options.
10/30/2030Expiration date for 150,000 Non-Qualified Stock Options.
02/22/2032Expiration date for 74,720 Non-Qualified Stock Options.
02/21/2033Expiration date for 94,298 Non-Qualified Stock Options.
02/20/2034Expiration date for 126,800 Non-Qualified Stock Options.
02/18/2035Expiration date for 75,871 Non-Qualified Stock Options.
02/17/2036Expiration date for 24,854 Non-Qualified Stock Options.

Recommendation

hold

The filing details routine executive compensation activities, including RSU vesting and new equity grants. While these grants align management incentives with shareholder value, they do not provide new fundamental information to alter an investment thesis, thus a 'hold' recommendation is appropriate for existing positions.

Keywords

Cognex, CGNX, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Equity Grant, Carl Gerst

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.